ROQUETTE FRERES (20240226016). STARCH BASED PRINTABLE MATERIALS simplified abstract
Contents
STARCH BASED PRINTABLE MATERIALS
Organization Name
Inventor(s)
Yuan-Siang Lui of Singapore (SG)
Keat-Theng Chow of Singapore (SG)
Rajeev Gokhale of Libertyville IL (US)
STARCH BASED PRINTABLE MATERIALS - A simplified explanation of the abstract
This abstract first appeared for US patent application 20240226016 titled 'STARCH BASED PRINTABLE MATERIALS
The instant invention pertains to a printable material for hot melt extrusion-based 3D printing (HME-3DP) containing pregelatinized cross-linked starch and hydroxypropyl methyl cellulose (HPMC). It also involves a process for 3D printing using this material and the products, particularly controlled release solid dosage forms, obtained through 3D printing.
- Pregelatinized cross-linked starch and HPMC are key components of the printable material for HME-3DP.
- The invention enables the creation of controlled release solid dosage forms through 3D printing.
- The process for 3D printing using this material allows for precise and customizable fabrication of pharmaceutical products.
- The combination of pregelatinized cross-linked starch and HPMC in the printable material enhances the printability and performance of the final products.
- The technology has potential applications in the pharmaceutical industry for the production of personalized medicine and complex drug delivery systems.
Potential Applications: - Pharmaceutical industry for personalized medicine - Production of complex drug delivery systems - Research and development of novel dosage forms
Problems Solved: - Enables precise fabrication of controlled release solid dosage forms - Enhances printability and performance of pharmaceutical products - Facilitates customization and personalization of medication
Benefits: - Improved control over drug release - Enhanced patient compliance - Tailored medication for individual needs
Commercial Applications: Title: Innovative 3D Printing Technology for Pharmaceutical Dosage Forms This technology can revolutionize the pharmaceutical industry by offering a more efficient and customizable method for producing controlled release solid dosage forms. The ability to create personalized medication through 3D printing opens up new possibilities for drug delivery systems and patient care.
Questions about the technology: 1. How does the combination of pregelatinized cross-linked starch and HPMC improve the performance of the printable material for HME-3DP? 2. What are the specific advantages of using 3D printing for the production of controlled release solid dosage forms in the pharmaceutical industry?
Original Abstract Submitted
the instant invention relates to a printable material for hot melt extrusion-based 3d printing (hme-3dp) comprising a pregelatinized cross-linked starch and hydroxypropyl methyl cellulose (hpmc). it also relates to a process for 3d printing using the same. it also relates to products, in particular controlled release solid dosage forms, obtained thereof by 3d printing.
